The atomic resolution structure of human aldose reductase reveals that rearrangement of a bound ligand allows the opening of the safety-belt loop

被引:15
作者
Biadene, Marianna
Hazemann, Isabelle
Cousido, Alexandra
Ginell, Steve
Jochimiak, Andrzej
Sheldrick, George M.
Podjarny, Alberto
Schneider, Thomas R.
机构
[1] Univ Gottingen, Lehrstuhl Strukturchem, D-37077 Gottingen, Germany
[2] ULP, INSERM, CNRS, IGBMC,UPR Biol Struct, F-67404 Illkirch Graffenstaden, France
[3] Argonne Natl Lab, Argonne, IL 60439 USA
[4] Inst Mol Oncol Fdn, IFOM, FIRC, I-20139 Milan, Italy
[5] European Inst Oncol, I-20141 Milan, Italy
来源
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY | 2007年 / 63卷
关键词
D O I
10.1107/S0907444907011997
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The crystal structure of human aldose reductase in complex with citrate has been determined to a resolution of 0.82 angstrom. The difference electron density for H atoms unequivocally shows that the cofactor is in the oxidized state corresponding to the situation after the catalytic event has occurred. A citrate, molecule bound to the active site has been modelled in two. different conformations. These two conformations correlate with a fully closed and a partially open conformation of the so-called safety-belt loop (Gly21.3-Ser226). The open conformation is observed for the first time with the cofactor bound to the protein and may be related to the initial phase of the opening of the safety belt. The structure suggests that after the catalytic event, a rearrangement of a bound ligand can trigger the opening of the safety-belt loop, thus initiating the release of the oxidized cofactor.
引用
收藏
页码:665 / 672
页数:8
相关论文
共 45 条
[1]   The structure of Apo R268A human aldose reductase: Hinges and latches that control the kinetic mechanism [J].
Bohren, KM ;
Brownlee, JM ;
Milne, AC ;
Gabbay, KH ;
Harrison, DHT .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2005, 1748 (02) :201-212
[2]   TYROSINE-48 IS THE PROTON DONOR AND HISTIDINE-110 DIRECTS SUBSTRATE STEREOCHEMICAL SELECTIVITY IN THE REDUCTION REACTION OF HUMAN ALDOSE REDUCTASE - ENZYME-KINETICS AND CRYSTAL-STRUCTURE OF THE Y48H MUTANT ENZYME [J].
BOHREN, KM ;
GRIMSHAW, CE ;
LAI, CJ ;
HARRISON, DH ;
RINGE, D ;
PETSKO, GA ;
GABBAY, KH .
BIOCHEMISTRY, 1994, 33 (08) :2021-2032
[3]  
BORHANI DW, 1992, J BIOL CHEM, V267, P24841
[4]   The structure of human aldose reductase bound to the inhibitor IDD384 [J].
Calderone, V ;
Chevrier, B ;
Van Zandt, M ;
Lamour, V ;
Howard, E ;
Poterszman, A ;
Barth, P ;
Mitschler, A ;
Lu, JH ;
Dvornik, DM ;
Klebe, G ;
Kraemer, O ;
Moorman, AR ;
Moras, D ;
Podjarny, A .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2000, 56 :536-540
[5]  
Costantino L, 1999, MED RES REV, V19, P3, DOI 10.1002/(SICI)1098-1128(199901)19:1<3::AID-MED2>3.3.CO
[6]  
2-Z
[7]   Synthesis and aldose reductase inhibitory activity of a new series of benzo[h]cinnolinone derivatives [J].
Costantino, L ;
Rastelli, G ;
Cignarella, G ;
Barlocco, D .
FARMACO, 2000, 55 (08) :544-552
[8]  
DUNLOP M, 2000, KIDNEY INT S, V77, P3
[9]   MECHANISM OF ALDOSE REDUCTASE INHIBITION - BINDING OF NADP+/NADPH AND ALRESTATIN-LIKE INHIBITORS [J].
EHRIG, T ;
BOHREN, KM ;
PRENDERGAST, FG ;
GABBAY, KH .
BIOCHEMISTRY, 1994, 33 (23) :7157-7165
[10]   Ultrahigh resolution drug design. II. Atomic resolution structures of human aldose reductase holoenzyme complexed with fidarestat and minalrestat: Implications for the binding of cyclic imide inhibitors [J].
El-Kabbani, O ;
Darmanin, C ;
Schneider, TR ;
Hazemann, I ;
Ruiz, F ;
Oka, M ;
Joachimiak, A ;
Schulze-Briese, C ;
Tomizaki, T ;
Mitschler, A ;
Podjarny, A .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2004, 55 (04) :805-813